Tcw Group Has Lowered Its Prologis (PLD) Holding; Utah Medical Products (UTMD) Sentiment Is 1.21

Thursday, 31 May 2018

Tcw Group Has Lowered Its Prologis (PLD) Holding; Utah Medical Products (UTMD) Sentiment Is 1.21

Prologis, Inc. (NYSE:PLD) Logo

Tcw Group Inc decreased Prologis Inc (PLD) stake by 1.54% reported in 2018Q1 SEC filing. Tcw Group Inc sold 5,686 shares as Prologis Inc (PLD)’s stock rose 5.06%. The Tcw Group Inc holds 364,700 shares with $22.97 million value, down from 370,386 last quarter. Prologis Inc now has $35.10 billion valuation. The stock increased 0.76% or $0.49 during the last trading session, reaching $64.8. About 3.04 million shares traded or 21.17% up from the average. Prologis, Inc. (NYSE:PLD) has risen 15.22% since May 30, 2017 and is uptrending. It has outperformed by 2.65% the S&P500.

Utah Medical Products Inc (UTMD) investors sentiment decreased to 1.21 in 2018 Q1. It’s down -0.54, from 1.75 in 2017Q4. The ratio dropped, as 40 active investment managers started new and increased holdings, while 33 sold and reduced their equity positions in Utah Medical Products Inc. The active investment managers in our database now own: 2.48 million shares, up from 2.40 million shares in 2017Q4. Also, the number of active investment managers holding Utah Medical Products Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 8 Reduced: 25 Increased: 22 New Position: 18.

Investors sentiment decreased to 1.04 in 2018 Q1. Its down 0.18, from 1.22 in 2017Q4. It is negative, as 43 investors sold PLD shares while 186 reduced holdings. 60 funds opened positions while 178 raised stakes. 483.90 million shares or 2.16% less from 494.61 million shares in 2017Q4 were reported. Glenmede Tru Co Na has invested 0.01% of its portfolio in Prologis, Inc. (NYSE:PLD). Cap Impact Advsrs has invested 1.11% in Prologis, Inc. (NYSE:PLD). Lmr Llp holds 0.21% or 31,645 shares. Strs Ohio stated it has 0.35% of its portfolio in Prologis, Inc. (NYSE:PLD). Franklin Res Inc holds 0.02% or 648,453 shares. Mogy Joel R Counsel has invested 0.44% in Prologis, Inc. (NYSE:PLD). Credit Suisse Ag holds 1.54 million shares. Westwood Gru reported 0.01% stake. Independent Order Of Foresters reported 22,511 shares stake. Presima holds 1.52 million shares. 10,417 are held by Miles Incorporated. 6,800 were reported by Wellington Shields Capital Management. Pictet Asset Mngmt Limited accumulated 421,381 shares. Ww Asset Mngmt holds 0.11% or 38,525 shares in its portfolio. Moreover, Employees Retirement System Of Texas has 0.31% invested in Prologis, Inc. (NYSE:PLD) for 368,700 shares.

Tcw Group Inc increased Schlumberger Ltd (NYSE:SLB) stake by 76,326 shares to 503,393 valued at $32.61 million in 2018Q1. It also upped Aes Corp (NYSE:AES) stake by 194,074 shares and now owns 10.61 million shares. Square Inc was raised too.

Analysts await Prologis, Inc. (NYSE:PLD) to report earnings on July, 17. They expect $0.71 EPS, down 15.48% or $0.13 from last year’s $0.84 per share. PLD’s profit will be $384.56 million for 22.82 P/E if the $0.71 EPS becomes a reality. After $0.80 actual EPS reported by Prologis, Inc. for the previous quarter, Wall Street now forecasts -11.25% negative EPS growth.

Among 26 analysts covering Prologis (NYSE:PLD), 18 have Buy rating, 1 Sell and 7 Hold. Therefore 69% are positive. Prologis had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Prologis, Inc. (NYSE:PLD) has “Buy” rating given on Tuesday, October 17 by Stifel Nicolaus. The stock of Prologis, Inc. (NYSE:PLD) earned “Hold” rating by Jefferies on Sunday, August 20. Stifel Nicolaus maintained the stock with “Buy” rating in Wednesday, October 21 report. The company was maintained on Monday, July 24 by Barclays Capital. The stock has “Buy” rating by BTIG Research on Thursday, August 25. Robert W. Baird maintained the shares of PLD in report on Monday, January 8 with “Buy” rating. The company was maintained on Tuesday, January 9 by BMO Capital Markets. Evercore upgraded the stock to “Outperform” rating in Monday, December 4 report. The rating was upgraded by SunTrust to “Buy” on Tuesday, September 5. The rating was maintained by Stifel Nicolaus with “Buy” on Wednesday, January 27.

More news for Utah Medical Products, Inc. (NASDAQ:UTMD) were recently published by: Nasdaq.com, which released: “New Research Coverage Highlights Franklin Electric Co., ForeScout Technologies, State Bank Financial, Meta …” on May 25, 2018. Nasdaq.com‘s article titled: “Utah Medical Products, Inc. Announces Quarterly Dividend” and published on May 08, 2018 is yet another important article.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $397.68 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 46.84 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

The stock increased 3.65% or $3.75 during the last trading session, reaching $106.6. About 8,769 shares traded. Utah Medical Products, Inc. (UTMD) has risen 57.69% since May 30, 2017 and is uptrending. It has outperformed by 45.12% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 13 selling transactions for $2.85 million activity.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Positions Chart